-
EP3390430
European procedure
Extract from the Register of European Patents
EP About this file: EP3390430
| EP3390430 - HUMAN IMMUNODEFICIENCY VIRUS ANTIGENS, VECTORS, COMPOSITIONS, AND METHODS OF USE THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 03.07.2020 Database last updated on 19.10.2024 | |
| Former | The patent has been granted Status updated on 26.07.2019 | ||
| Former | Grant of patent is intended Status updated on 14.04.2019 | ||
| Former | Request for examination was made Status updated on 21.09.2018 | ||
| Former | The international publication has been made Status updated on 23.06.2017 | ||
| Former | unknown Status updated on 16.01.2017 | Most recent event Tooltip | 03.07.2020 | No opposition filed within time limit | published on 05.08.2020 [2020/32] | Applicant(s) | For all designated states Janssen Vaccines & Prevention B.V. Archimedesweg 4 2333 CN Leiden / NL | [2018/43] | Inventor(s) | 01 /
LANGEDIJK, Johannes, Petrus, Maria Archimedesweg 4-6 2333 CN Leiden / NL | 02 /
CALLENDRET, Benoit, Christophe, Stephan Archimedesweg 4-6 2333 CN Leiden / NL | 03 /
VAN MANEN, Danielle Archimedesweg 4-6 2333 CN Leiden / NL | 04 /
KRARUP, Anders Archimedesweg 4-6 2333 CN Leiden / NL | 05 /
STITZ, Jörn Archimedesweg 4-6 2333 CN Leiden / NL | 06 /
WEGMANN, Frank Archimedesweg 4-6 2333 CN Leiden / NL | 07 /
VELLINGA, Jort Archimedesweg 4-6 2333 CN Leiden / NL | [2019/34] |
| Former [2018/43] | 01 /
LANGEDIJK, Johannes, Petrus, Maria Archimedesweg 4-6 2333 CN Leiden / NL | Representative(s) | Verhage, Richard Abraham, et al Janssen Vaccines & Prevention B.V. Archimedesweg 4-6 2333 CN Leiden / NL | [2018/43] | Application number, filing date | 16822410.3 | 15.12.2016 | [2018/43] | WO2016EP81159 | Priority number, date | EP20150200138 | 15.12.2015 Original published format: EP 15200138 | EP20160194124 | 17.10.2016 Original published format: EP 16194124 | [2018/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017102929 | Date: | 22.06.2017 | Language: | EN | [2017/25] | Type: | A1 Application with search report | No.: | EP3390430 | Date: | 24.10.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.06.2017 takes the place of the publication of the European patent application. | [2018/43] | Type: | B1 Patent specification | No.: | EP3390430 | Date: | 28.08.2019 | Language: | EN | [2019/35] | Search report(s) | International search report - published on: | EP | 22.06.2017 | Classification | IPC: | C07K14/16 | [2018/43] | CPC: |
A61P31/18 (EP,CN);
A61K39/21 (EP,IL,KR,US);
C07K14/005 (CN,IL,KR,US);
A61K39/12 (CN);
A61P37/04 (EP);
A61P43/00 (EP);
C07K14/16 (CN);
C07K14/162 (CN,US);
C12N15/86 (CN,IL,KR,US);
C12N15/861 (CN,IL,US);
C12N7/00 (EP,CN,IL,KR,US);
A61K2039/5256 (CN,IL,KR,US);
C12N2710/10343 (CN,IL,KR,US);
C12N2740/16111 (CN,US);
C12N2740/16122 (CN,IL,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/43] | Extension states | BA | 21.06.2018 | ME | 21.06.2018 | Validation states | MA | 21.06.2018 | MD | 21.06.2018 | Title | German: | ANTIGENE DES HUMANEN IMMUNDEFIZIENZ-VIRUS, VEKTOREN, ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON | [2018/43] | English: | HUMAN IMMUNODEFICIENCY VIRUS ANTIGENS, VECTORS, COMPOSITIONS, AND METHODS OF USE THEREOF | [2018/43] | French: | ANTIGÈNES DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE, VECTEURS, COMPOSITIONS, ET LEURS PROCÉDÉS D'UTILISATION | [2018/43] | Entry into regional phase | 21.06.2018 | National basic fee paid | 21.06.2018 | Designation fee(s) paid | 21.06.2018 | Examination fee paid | Examination procedure | 21.06.2018 | Examination requested [2018/43] | 21.06.2018 | Date on which the examining division has become responsible | 25.01.2019 | Amendment by applicant (claims and/or description) | 15.04.2019 | Communication of intention to grant the patent | 15.07.2019 | Fee for grant paid | 15.07.2019 | Fee for publishing/printing paid | 15.07.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | EP19186284.6 / EP3584252 | EP21185351.0 | Opposition(s) | 03.06.2020 | No opposition filed within time limit [2020/32] | Fees paid | Renewal fee | 12.12.2018 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2010059732 (BETH ISRAEL HOSPITAL [US], et al) [A] 1-15 * claim 9; sequences 2,30 *; | [A] - "RecName: Full=Endogenous retrovirus group K member 9 Env polyprotein {ECO:0000256|SAAS:SAAS00159347}; AltName: Full=Endogenous retrovirus group K member 113 Env polyprotein {ECO:0000256|SAAS:SAAS00159454}; AltName: Full=Endogenous retrovirus group K member 13-1 Env polyprotein {ECO:0000256|SAAS:SAAS", UNIPROT, (20050301), XP002757477 [A] 1-15 * the whole document * | [A] - COMPANS R W ET AL, "Recombinant protein gp41 heterologous transmembrane region, SEQ ID 1", GENESEQ,, (20090115), XP002757478 [A] 1-15 * the whole document * | [A] - MARASCO W A, "Transmembrane domain peptide, SEQ ID 14", GENESEQ,, (20060126), XP002757479 [A] 1-15 * the whole document * | [A] - "GCN4 fusion linker peptide, SEQ ID NO 3", GENESEQ,, (20070111), XP002757480 [A] 1-15 * the whole document * |